Read + Share
Betjes MGH, Kho MML, Litjens NHR, de Weerd AE, et al. Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of
Transplanted Kidneys. Transplant Proc 2021;53:2206-2211.
PMID: 34376313
|
 |
|
Betjes MGH, Kho MML, Litjens NHR, de Weerd AE, et al. Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of
Transplanted Kidneys. Transplant Proc 2021;53:2206-2211.
PMID: 34376313
|
|
|
|